SSY Group Limited (2005.HK)
HKD 3.31
(-2.93%)
HKD 3.31
(-2.93%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.48 Billion HKD | 1.44% |
| 2022 | 3.43 Billion HKD | 13.23% |
| 2021 | 3.03 Billion HKD | 17.69% |
| 2020 | 2.58 Billion HKD | -7.6% |
| 2019 | 2.79 Billion HKD | 7.18% |
| 2018 | 2.6 Billion HKD | 44.22% |
| 2017 | 1.8 Billion HKD | 48.44% |
| 2016 | 1.21 Billion HKD | 15.99% |
| 2015 | 1.04 Billion HKD | -1.49% |
| 2014 | 1.06 Billion HKD | -13.55% |
| 2013 | 1.23 Billion HKD | 19.29% |
| 2012 | 1.03 Billion HKD | 13.07% |
| 2011 | 913.69 Million HKD | -7.86% |
| 2010 | 991.62 Million HKD | 15.39% |
| 2009 | 859.36 Million HKD | 18.12% |
| 2008 | 727.53 Million HKD | 21.39% |
| 2007 | 599.32 Million HKD | 35.09% |
| 2006 | 443.63 Million HKD | 3.11% |
| 2005 | 430.25 Million HKD | 1.04% |
| 2004 | 425.83 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.84 Billion HKD | 0.0% |
| 2023 Q2 | 1.88 Billion HKD | 0.0% |
| 2023 Q4 | 1.59 Billion HKD | 0.0% |
| 2023 FY | 3.48 Billion HKD | 1.44% |
| 2022 Q4 | 1.57 Billion HKD | 0.0% |
| 2022 FY | 3.43 Billion HKD | 13.23% |
| 2022 Q2 | 1.86 Billion HKD | 0.0% |
| 2021 Q4 | 1.64 Billion HKD | 0.0% |
| 2021 Q2 | 1.42 Billion HKD | 0.0% |
| 2021 FY | 3.03 Billion HKD | 17.69% |
| 2020 Q4 | 1.5 Billion HKD | 0.0% |
| 2020 Q2 | 1.07 Billion HKD | 0.0% |
| 2020 FY | 2.58 Billion HKD | -7.6% |
| 2019 FY | 2.79 Billion HKD | 7.18% |
| 2019 Q2 | 1.44 Billion HKD | 0.0% |
| 2019 Q4 | 1.34 Billion HKD | 0.0% |
| 2018 Q4 | 1.28 Billion HKD | 0.0% |
| 2018 FY | 2.6 Billion HKD | 44.22% |
| 2018 Q2 | 1.32 Billion HKD | 0.0% |
| 2017 Q2 | 728.13 Million HKD | 0.0% |
| 2017 FY | 1.8 Billion HKD | 48.44% |
| 2017 Q4 | 1.07 Billion HKD | 0.0% |
| 2016 Q4 | 667.36 Million HKD | 0.0% |
| 2016 Q2 | 550.07 Million HKD | 0.0% |
| 2016 FY | 1.21 Billion HKD | 15.99% |
| 2015 FY | 1.04 Billion HKD | -1.49% |
| 2015 Q4 | 555.86 Million HKD | 0.0% |
| 2015 Q2 | 493.7 Million HKD | 0.0% |
| 2014 Q2 | 516.68 Million HKD | 0.0% |
| 2014 Q4 | 548.72 Million HKD | 0.0% |
| 2014 FY | 1.06 Billion HKD | -13.55% |
| 2013 Q3 | 308.08 Million HKD | -51.09% |
| 2013 FY | 1.23 Billion HKD | 19.29% |
| 2013 Q4 | 266.35 Million HKD | -13.55% |
| 2013 Q2 | 629.84 Million HKD | 104.44% |
| 2013 Q1 | 308.08 Million HKD | 0.0% |
| 2012 Q4 | 308.08 Million HKD | 19.29% |
| 2012 Q1 | 258.27 Million HKD | 0.0% |
| 2012 FY | 1.03 Billion HKD | 13.07% |
| 2012 Q2 | 258.27 Million HKD | 0.0% |
| 2012 Q3 | 258.27 Million HKD | 0.0% |
| 2011 Q3 | 228.42 Million HKD | 0.0% |
| 2011 Q2 | 228.42 Million HKD | 0.0% |
| 2011 Q1 | 228.42 Million HKD | 0.0% |
| 2011 FY | 913.69 Million HKD | -7.86% |
| 2011 Q4 | 258.27 Million HKD | 13.07% |
| 2010 FY | 991.62 Million HKD | 15.39% |
| 2010 Q4 | 228.42 Million HKD | -7.86% |
| 2010 Q1 | 247.9 Million HKD | 0.0% |
| 2010 Q3 | 247.9 Million HKD | 0.0% |
| 2010 Q2 | 247.9 Million HKD | 0.0% |
| 2009 Q4 | 247.9 Million HKD | 15.39% |
| 2009 Q2 | 214.84 Million HKD | 0.0% |
| 2009 Q1 | 214.84 Million HKD | 0.0% |
| 2009 FY | 859.36 Million HKD | 18.12% |
| 2009 Q3 | 214.84 Million HKD | 0.0% |
| 2008 Q4 | 214.84 Million HKD | 18.12% |
| 2008 FY | 727.53 Million HKD | 21.39% |
| 2008 Q3 | 181.88 Million HKD | 0.0% |
| 2008 Q2 | 181.88 Million HKD | 0.0% |
| 2008 Q1 | 181.88 Million HKD | 0.0% |
| 2007 Q4 | 181.88 Million HKD | 21.39% |
| 2007 FY | 599.32 Million HKD | 35.09% |
| 2007 Q2 | 149.83 Million HKD | 0.0% |
| 2007 Q1 | 149.83 Million HKD | -0.0% |
| 2007 Q3 | 149.83 Million HKD | -0.0% |
| 2006 Q1 | 110.9 Million HKD | -0.0% |
| 2006 Q4 | 149.83 Million HKD | 35.09% |
| 2006 FY | 443.63 Million HKD | 3.11% |
| 2006 Q3 | 110.9 Million HKD | -0.0% |
| 2006 Q2 | 110.9 Million HKD | 0.0% |
| 2005 Q3 | 107.56 Million HKD | 0.0% |
| 2005 Q1 | 107.56 Million HKD | 0.0% |
| 2005 FY | 430.25 Million HKD | 1.04% |
| 2005 Q2 | 107.56 Million HKD | 0.0% |
| 2005 Q4 | 110.9 Million HKD | 3.11% |
| 2004 FY | 425.83 Million HKD | 0.0% |
| 2004 Q1 | 106.45 Million HKD | -0.0% |
| 2004 Q2 | 106.45 Million HKD | 0.0% |
| 2004 Q3 | 106.45 Million HKD | -0.0% |
| 2004 Q4 | 107.56 Million HKD | 1.04% |
| 2003 Q4 | 106.45 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -1983.888% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 46.518% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -12024.045% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -783.755% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 9900.239% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -532.888% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -126.674% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -640.343% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -1510.67% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -992.362% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -462.34% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 91.954% |